|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 672.15 USD | -0.67% |
|
+1.37% | -12.92% |
| 20/07 | Goldman Sachs Adjusts Price Target on Regeneron Pharmaceuticals to $965 From $968, Maintains Buy Rating | MT |
| 16/07 | Merck gets US FDA nod for first-in-its-class oral cholesterol drug | RE |
Quotes 5-day view: Regeneron Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 14/07/2026 | 15/07/2026 | 16/07/2026 | 17/07/2026 | 20/07/2026 | |
|---|---|---|---|---|---|
| Last | $656.12 | $664.45 | $678.94 | $676.69 | $672.15 |
| Volume | 4,77,991 | 5,55,419 | 7,30,245 | 6,48,400 | 6,24,791 |
| Change | -1.05% | +1.27% | +2.18% | -0.33% | -0.67% |
| Opening | $658.00 | $656.11 | $666.28 | $676.05 | $674.72 |
| High | $663.10 | $669.10 | $680.29 | $691.13 | $681.74 |
| Low | $653.31 | $648.66 | $661.38 | $672.31 | $669.88 |
Performance
| 1 day | -0.67% | ||
| 1 week | +1.37% | ||
| Current month | +7.80% | ||
| 1 month | +10.20% | ||
| 3 months | -10.31% | ||
| 6 months | -8.40% | ||
| Current year | -12.92% | ||
| 1 year | +23.89% | ||
| 3 years | -7.04% | ||
| 5 years | +14.46% | ||
| 10 years | +74.72% |
Volumes
marketsDaily volume
6,24,791
Estimated daily volume
6,24,791
Avg. Volume 20 sessions
7,46,464
Daily volume ratio
0.84
Avg. Volume 20 sessions USD
50,17,35,777.6
Record volume 1
2,82,82,394
Record volume 2
1,53,85,360
Record volume 3
1,36,46,090
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
68,38,38,90,358
Net sales (USD)
14,34,29,00,000
Number of employees
15,343
Sales / Employee (USD)
9,34,817
Free-Float
72.33 %
Free-Float capitalization (USD)
67,83,99,05,248
Average Daily Capital Traded
0.73%
Indicators
Moving average 5 days
669.67
Moving average 20 days
645.6
Moving average 50 days
645.82
Moving average 100 days
698.16
Price spread / (MMA5)
-0.37%
Price spread / (MMA20)
-3.95%
Price spread / (MMA50)
-3.92%
Price spread / (MMA100)
+3.87%
STIM
RSI 9 days
66.66
RSI 14 days
61.97
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | +1.37% | +23.89% | -7.04% | 6.84TCr | |
| -0.54% | +1.02% | +36.12% | +189.96% | 5.17TCr | |
| -3.65% | +34.50% | +34.50% | +34.50% | 4.21TCr | |
| -1.48% | -1.77% | -52.69% | -54.78% | 4.11TCr | |
| -2.93% | -4.34% | +59.97% | -27.21% | 2.95TCr | |
| -3.77% | -11.22% | +90.31% | -52.32% | 2.36TCr | |
| -1.36% | +1.24% | +70.42% | +80.67% | 2.31TCr | |
| -1.46% | +1.22% | +2.82% | +177.90% | 2.05TCr | |
| +0.26% | +0.39% | +70.47% | +126.52% | 1.65TCr | |
| -0.76% | -2.79% | +73.64% | +134.15% | 1.58TCr | |
| Average | -1.64% | -1.42% | +40.95% | +60.24% | 3.32TCr | |
| Weighted average by Cap. | -1.60% | -0.96% | +32.20% | +48.83% |
Historical Quotes: Regeneron Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
d2e2038c177dee4e660c48dca51.GrWQJhti9Dn0JKQBYZukWQFxu0ccpgJWsD9cAnZmNow.WOLkcXpVxVabbMFSM_jBKGsciTRmlTABg14YVzAOZuNjw_QQa1OmSZJX_Q
| Date | Price | Volume | Total |
|---|---|---|---|
| 01:30:00 am | 672.15 | 1,91,714 | 4,33,287 |
| 01:29:59 am | 672.34 | 100 | 2,41,573 |
| 01:29:59 am | 672.31 | 48 | 2,41,473 |
| 01:29:59 am | 672.31 | 50 | 2,41,425 |
| 01:29:59 am | 672.21 | 40 | 2,41,375 |
| 01:29:59 am | 672.06 | 40 | 2,41,335 |
| 01:29:58 am | 671.97 | 40 | 2,41,295 |
| 01:29:57 am | 672.18 | 40 | 2,41,255 |
| 01:29:57 am | 672.16 | 40 | 2,41,215 |
| 01:29:57 am | 672.03 | 40 | 2,41,175 |
Course Extremes
| 1 week | 648.66 |  | 691.13 |
| 1 month | 594.9 | | 691.13 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
Monthly variations
Annual variations
| 2026 | -12.92% | ||
| 2025 | +8.36% | ||
| 2024 | -18.90% | ||
| 2023 | +21.73% | ||
| 2022 | +14.25% | ||
| 2021 | +30.72% | ||
| 2020 | +28.66% | ||
| 2019 | +0.53% | ||
| 2018 | -0.65% | ||
| 2017 | +2.42% | ||
| 2016 | -32.38% | ||
| 2015 | +32.33% | ||
| 2014 | +49.05% | ||
| 2013 | +60.89% | ||
| 2012 | +208.62% | ||
| 2011 | +68.84% | ||
| 2010 | +35.77% | ||
| 2009 | +31.70% | ||
| 2008 | -23.98% | ||
| 2007 | +20.33% | ||
| 2006 | +26.23% | ||
| 2005 | +72.64% | ||
| 2004 | -37.39% | ||
| 2003 | -20.53% | ||
| 2002 | -34.27% | ||
| 2001 | -20.15% | ||
| 2000 | +176.59% | ||
| 1999 | +72.88% | ||
| 1998 | -13.87% | ||
| 1997 | -46.90% | ||
| 1996 | +26.47% | ||
| 1995 | +325.00% | ||
| 1994 | -80.65% | ||
| 1993 | +29.17% | ||
| 1992 | -33.79% | ||
| 1991 | -14.20% |
- Stock Market
- Stocks
- REGN Stock
- Quotes Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition